India's Serum Institute delays vaccines for private sale in Bangladesh; focus on state campaigns

AstraZeneca has been embroiled in a dispute in Europe after it said it would have to cut supplies of its vaccine there in the first quarter.
Source: The Economic Times - Category: Consumer Health News Source Type: news